Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-25 @ 7:34 PM
Study NCT ID:
NCT05533632
Status:
COMPLETED
Last Update Posted:
2025-09-24
First Post:
2022-09-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-18
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-06
First Submit QC Date:
None
Study First Post Date:
2022-09-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-16
Results First Submit QC Date:
None
Results First Post Date:
2025-02-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-23
Last Update Post Date:
2025-09-24
Last Update Post Date Type:
ESTIMATED